EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, K. S.
Right arrow Articles by Schook, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, K. S.
Right arrow Articles by Schook, L. B.
Experimental Biology and Medicine 229:866-875 (2004)
© 2004 Society for Experimental Biology and Medicine


MINIREVIEW

Genomics and Clinical Medicine: Rationale for Creating and Effectively Evaluating Animal Models

Kelly S. Swanson*, Meredith J. Mazur*, Kapil Vashisht*,{dagger}, Laurie A. Rund*, Jonathan E. Beever{ddagger}, Christopher M. Counter§ and Lawrence B. Schook*,{ddagger},1

* Laboratory of Comparative Genomics, University of Illinois, Urbana, Illinois 61801; {dagger} Department of Veterinary Pathobiology, University of Illinois, Urbana, Illinois 61801; {ddagger} Laboratory of Molecular Genetics, Department of Animal Sciences, University of Illinois, Urbana, Illinois 61801; and § Department of Pharmacology and Oncology, Duke University Medical Center, Durham, North Carolina 27710

To whom requests for reprints should be addressed at 1 329 Edward R. Madigan Laboratory, University of Illinois, 1201 West Gregory Drive, Urbana, IL 61801. E-mail: schook{at}uiuc.edu

Because resolving human complex diseases is difficult, appropriate biomedical models must be developed and validated. In the past, researchers have studied diseases either by characterizing a human clinical disease and choosing the most appropriate animal model, or by characterizing a naturally occurring or induced mutant animal and identifying which human disease it best resembled. Although there has been a great deal of progress through the use of these methods, such models have intrinsic faults that limit their relevance to clinical medicine. The recent advent of techniques in molecular biology, genomics, transgenesis, and cloning furnishes investigators with the ability to study vertebrates (e.g., pigs, cows, chickens, dogs) with greater precision and utilize them as model organisms. Comparative and functional genomics and proteomics provide effective approaches for identifying the genetic and environmental factors responsible for complex diseases and in the development of prevention and treatment strategies and therapeutics. By identifying and studying homologous genes across species, researchers are able to accurately translate and apply experimental data from animal experiments to humans. This review supports the hypothesis that associated enabling technologies can be used to create, de novo, appropriate animal models that recapitulate the human clinical manifestation. Comparative and functional genomic and proteomic techniques can then be used to identify gene and protein functions and the interactions responsible for disease phenotypes, which aids in the development of prevention and treatment strategies.

Key Words: genomics • animal models • transgenesis • recombineering




This article has been cited by other articles:


Home page
J. Nutr.Home page
W. G. Bergen and H. J. Mersmann
Comparative Aspects of Lipid Metabolism: Impact on Contemporary Research and Use of Animal Models
J. Nutr., November 1, 2005; 135(11): 2499 - 2502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Experimental Biology and Medicine.